4-[[1-[4-(2-ethylphenyl)-4-methyliminobutyl]piperidin-4-yl]amino]chromen-2-one
C27H33N3O2 — CID 145101478
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[[1-[4-(2-ethylphenyl)-4-methyliminobutyl]piperidin-4-yl]amino]chromen-2-one
4-[[1-[4-(2-ethylphenyl)-4-methyliminobutyl]piperidin-4-yl]amino]chromen-2-one (PubChem CID 145101478) has the molecular formula C27H33N3O2 and a molecular weight of 431.58 g/mol. Its IUPAC name is 4-[[1-[4-(2-ethylphenyl)-4-methyliminobutyl]piperidin-4-yl]amino]chromen-2-one.
Molecular Properties
| Compound Name | 4-[[1-[4-(2-ethylphenyl)-4-methyliminobutyl]piperidin-4-yl]amino]chromen-2-one |
|---|---|
| PubChem CID | 145101478 |
| Molecular Formula | C27H33N3O2 |
| Molecular Weight | 431.58 g/mol |
| Exact Mass | 431.26 |
| IUPAC Name | 4-[[1-[4-(2-ethylphenyl)-4-methyliminobutyl]piperidin-4-yl]amino]chromen-2-one |
| SMILES | CCc1ccccc1/C(CCCN1CCC(Nc2cc(=O)oc3ccccc23)CC1)=N/C |
| InChI | InChI=1S/C27H33N3O2/c1-3-20-9-4-5-10-22(20)24(28-2)12-8-16-30-17-14-21(15-18-30)29-25-19-27(31)32-26-13-7-6-11-23(25)26/h4-7,9-11,13,19,21,29H,3,8,12,14-18H2,1-2H3/b28-24+ |
| InChIKey | SCWIBSJJVQEWKX-ZZIIXHQDSA-N |
| XLogP | 5.13 |
| TPSA | 57.84 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 431.58 |
| LogP ≤ 5 | 5.13 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'cumarine', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 145101478 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.